Cargando…

A phase II study of carboplatin in adenocarcinoma of the oesophagus.

Detalles Bibliográficos
Autores principales:	Steel, A., Cullen, M. H., Robertson, P. W., Matthews, H. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1988
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246802/ https://www.ncbi.nlm.nih.gov/pubmed/3061440

Ejemplares similares

Barrett's oesophagus and adenocarcinoma
por: Caygill, Christine PJ, et al.
Publicado: (2004)

Primary adenocarcinoma of the upper oesophagus
por: Verma, Yash P, et al.
Publicado: (2013)

E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus
por: Wijnhoven, B P L, et al.
Publicado: (1999)

Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction
por: Wainberg, Z A, et al.
Publicado: (2011)

Adenocarcinoma of the oesophagus: is it gastric cancer?
por: Quante, Michael, et al.
Publicado: (2023)

Adenocarcinoma of the Oesophagus and Ectopic Gastric Mucosa
por: Morson, B. C., et al.
Publicado: (1952)

Risk of adenocarcinomas of the oesophagus and gastric cardia in patients hospitalized for asthma
por: Ye, W, et al.
Publicado: (2001)

Metallothionein in human oesophagus, Barrett's epithelium and adenocarcinoma
por: Coyle, P, et al.
Publicado: (2002)

Achalasia leading to diagnosis of adenocarcinoma of the oesophagus
por: Segal, Jonathan, et al.
Publicado: (2017)

A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas.
por: Rigg, A., et al.
Publicado: (1997)

Socioeconomic status and risk of adenocarcinoma of the oesophagus and cancer of the gastric cardia in Scotland
por: Brewster, D H, et al.
Publicado: (2000)

Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid
por: Hinnen, P, et al.
Publicado: (2000)

Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma
por: Gregson, Eleanor M, et al.
Publicado: (2016)

Trends in the incidence of adenocarcinoma of the oesophagus and cardia in the Netherlands 1989–2003
por: van Blankenstein, M, et al.
Publicado: (2007)

Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study
por: van Meerten, E, et al.
Publicado: (2006)

Carcinoma of the oesophagus
por: Seitz, J F, et al.
Publicado: (2001)

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma
por: Patil, Vijay Maruti, et al.
Publicado: (2017)

Dietary antioxidant intake and the risk of developing Barrett’s oesophagus and oesophageal adenocarcinoma
por: Kang, James H-E, et al.
Publicado: (2018)

Congenital Atresia of the Œsophagus
por: Gailey, A. A. H., et al.
Publicado: (1951)

Phase II study of irinotecan combined with carboplatin in previously untreated small-cell lung cancer
por: Kinoshita, A, et al.
Publicado: (2006)

MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma
por: Fisher, O M, et al.
Publicado: (2015)

Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial.
por: Zielinski, C. C., et al.
Publicado: (1998)

Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases
por: Leone, Jose Pablo, et al.
Publicado: (2020)

A phase II study of carboplatin and vinorelbine as second-line treatment for advanced breast cancer.
por: Iaffaioli, R. V., et al.
Publicado: (1995)

Diverticulum of the Œsophagus
por: Clement, A. W.
Publicado: (1891)

Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia.
por: Gleeson, C. M., et al.
Publicado: (1998)

A multicentre phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site (CUPS).
por: Warner, E., et al.
Publicado: (1998)

Pilot early phase II study of decitabine and carboplatin in patients with advanced melanoma
por: van der Westhuizen, Andre, et al.
Publicado: (2020)

A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study
por: Türeci, O, et al.
Publicado: (2019)

Computational modelling suggests that Barrett’s oesophagus may be the precursor of all oesophageal adenocarcinomas
por: Curtius, Kit, et al.
Publicado: (2021)

Phase I-II study of carboplatin vincristine methotrexate and bleomycin (COMB) in carcinoma of the cervix.
por: Rustin, G. J., et al.
Publicado: (1988)

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma
por: Ceresoli, G L, et al.
Publicado: (2013)

Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma
por: Franceschi, E, et al.
Publicado: (2004)

Endoscopic Management of Dysplastic Barrett’s Oesophagus and Early Oesophageal Adenocarcinoma
por: Eusebi, Leonardo Henry, et al.
Publicado: (2023)

A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA)
por: Cortesi, L., et al.
Publicado: (2023)

Radiotherapy and olaparib in combination for carcinoma of the oesophagus: A phase I study
por: Sheikh, Hamid, et al.
Publicado: (2023)

A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide.
por: McClay, E. F., et al.
Publicado: (1993)

Prediction of a positive circumferential resection margin at surgery following neoadjuvant chemotherapy for adenocarcinoma of the oesophagus
por: Knight, W. R. C., et al.
Publicado: (2019)

Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas
por: Soldes, O S, et al.
Publicado: (1999)

The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma
por: den Hoed, C M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_leaqcsr5aev4m1b0ljo49v1ugm